Putative cancer stem cells in cutaneous malignancies

Experimental Dermatology

Volumn 16, Issue 4, 2007, Pages 297-301

  Kamstrup, Maria R ^a,b   Gniadecki, Robert ^a   Skovgaard, Gunhild L ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cancer; Skin; Stem cell

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

BASAL CELL CARCINOMA; BRAIN TUMOR; BREAST CANCER; CANCER RELAPSE; CANCER STEM CELL; CHEMICAL CARCINOGENESIS; CYTOREDUCTIVE SURGERY; DRUG MEGADOSE; EPIDERMIS CELL; HUMAN; KERATINOCYTE; LEUKEMIA; MELANOCYTE; MELANOMA; MYCOSIS FUNGOIDES; NONHUMAN; PAPILLOMA; PATHOGENESIS; REVIEW; SKIN CANCER; SKIN CARCINOMA; SKIN LYMPHOMA; SQUAMOUS CELL CARCINOMA; T CELL LYMPHOMA; TUMOR GROWTH;

ANIMALS; HUMANS; LYMPHOMA, T-CELL; MELANOMA; SKIN NEOPLASMS; STEM CELLS;

EID: 33947120191     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00547.x     Document Type: Review

References (73)

1. Sirard C, Lapidot T, Vormoor J et al. Normaland leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 87: 1539-1548.
2. Cobaleda C, Gutierrez-Cianca N, Perez-Losada J et al. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood 2000: 95: 1007-1013.
3. Singh S K, Clarke I D, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003: 63: 5821-5828.
4. Al Hajj M, Wicha M S, Benito-Hernandez A, Morrison S J, Clarke M F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100: 3983-3988.
5. Bruce W R, Van Der Gaag H A. Quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 1963: 199: 79-80.
6. Moore M A, Williams N, Metcalf D. In vitro colony formation by normal and leukemic human hematopoietic cells: Characterization of the colony-forming cells. J Natl Cancer Inst, 1973: 50: 603-623.
7. Nowell P C. The clonal evolution of tumor cell populations. Science 1976: 194: 23-28.
8. Reya T, Morrison S J, Clarke M F, Weissman I L. Stem cells, cancer, and cancer stem cells. Nature 2001: 414: 105-111.
9. Lajtha L G. Stem cell concepts. Differentiation 1979: 14: 23-34.
10. Leong K G, Karsan A. Recent insights into the role of notch signaling in tumorigenesis. Blood 2006: 107: 2223-2233.
11. Taipale J, Beachy P A. The Hedgehog and Wnt signalling pathways in cancer. Nature 2001: 411: 349-354.
12. Yilmaz O H, Valdez R, Theisen B K et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006: 441: 475-482.
13. Morrison S J, Weissman I L. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994: 1: 661-673.
14. Reynolds B A, Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996: 175: 1-13.
15. Spangrude G J, Heimfeld S, Weissman I L. Purification and characterization of mouse hematopoietic stem cells. Science 1988: 241: 58-62.
16. Passegue E, Jamieson C H, Ailles L E, Weissman I L. Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics ? Proc Natl Acad Sci USA 2003: 100: 11842-11849.
17. Takahashi N, Miura I, Saitoh K, Miura A B. Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood 1998: 92: 4758-4763.
18. Fialkow P J, Denman A M, Jacobson R J, Lowenthal M N. Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest 1978: 62: 815-823.
19. Fialkow P J, Jacobson R J, Papayannopoulou T. Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977: 63: 125-130.
20. Cozzio A, Passegue E, Ayton P M, Karsunky H, Cleary M L, Weissman I L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003: 17: 3029-3035.
21. Jaiswal S, Traver D, Miyamoto T, Akashi K, Lagasse E, Weissman I L. Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proc Natl Acad Sci USA 2003: 100: 10002-10007.
22. Borue X, Lee S, Grove J et al. Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 2004: 165: 1767-1772.
23. Brittan M, Braun K M, Reynolds L E et al. Bone marrow cells engraft within the epidermis and proliferate in vivo with no evidence of cell fusion. J Pathol 2005: 205: 1-13.
24. Houghton J, Stoicov C, Nomura S et al. Gastric cancer originating from bone marrow-derived cells. Science 2004: 306: 1568-1571.
25. Bjerkvig R, Tysnes B B, Aboody K S, Najbauer J, Terzis A J. Opinion: The origin of the cancer stem cell: Current controversies and new insights. Nat Rev Cancer 2005: 5: 899-904.
26. Watt F M. Stem cell fate and patterning in mammalian epidermis. Curr Opin Genet Dev 2001: 11: 410-417.
27. Blanpain C, Lowry W E, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 2004: 118: 635-648.
28. Taylor G, Lehrer M S, Jensen P J, Sun T T, Lavker R M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 2000: 102: 451-461.
29. Tumbar T, Guasch G, Greco V et al. Defining the epithelial stem cell niche in skin. Science 2004: 303: 359-363.
30. VanDuuren B L, Sivak A, Katz C, Seidman I, Melchionne S. The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin. Cancer Res 1975: 35: 502-505.
31. Morris R J, Coulter K, Tryson K, Steinberg S R. Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling. Cancer Res 1997: 57: 3436-3443.
32. Brown K, Strathdee D, Bryson S, Lambie W, Balmain A. The malignant capacity of skin tumours induced by expression of a mutant H-Ras transgene depends on the cell type targeted. Curr Biol 1998: 8: 516-524.
33. Bailleul B, Surani M A, White S et al. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 1990: 62: 697-708.
34. Morris R J, Tryson K A, Wu K Q. Evidence that the epidermal targets of carcinogen action are found in the interfollicular epidermis of infundibulum as well as in the hair follicles. Cancer Res 2000: 60: 226-229.
35. Morris R J A. Perspective on keratinocyte stem cells as targets for skin carcinogenesis. Differentiation 2004: 72: 381-386.
36. Goodell M A, Brose K, Paradis G, Conner A S, Mulligan R C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996: 183: 1797-1806.
37. Zhou S, Schuetz J D, Bunting K D et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001: 7: 1028-1034.
38. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang D G. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and A. Cancer Res 2005: 65: 6207-6219.
39. Chen J S, Pardo F S, Wang-Rodriguez J et al. EGFR regulates the side population in head and neck squamous cell carcinoma. Laryngoscope 2006: 116: 401-406.
40. Locke M, Heywood M, Fawell S, Mackenzie I C. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 2005: 65: 8944-8950.
41. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 1987: 84: 2302-2306.
42. Bale A E, Yu K P. The Hedgehog pathway and basal cell carcinomas. Hum Mol Genet 2001: 10: 757-762.
43. Oro A E, Higgins K M, Hu Z, Bonifas J M, Epstein Jr E H, Scott M P. Basal cell carcinomas in mice overexpressing sonic Hedgehog. Science 1997: 276: 817-821.
44. Hutchin M E, Kariapper M S, Grachtchouk M et al. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: Conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev 2005: 19: 214-223.
45. Jin H, Aiyer A, Su J et al. Homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 2006: 116: 652-662.
46. Li H C, Stoicov C, Rogers A B, Houghton J. Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol 2006: 12: 363-371.
47. Aractingi S, Kanitakis J, Euvrard S et al. Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res 2005: 65: 1755-1760.
48. Nishimura E K, Jordan S A, Oshima H et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 2002: 416: 854-860.
49. Amoh Y, Li L, Katsuoka K, Penman S, Hoffman R M. Multipotent nestin-positive, keratin-negative hair-follicle bulge stem cells can form neurons. Proc Natl Acad Sci USA 2005: 102: 5530-5534.
50. Fang D, Nguyen T K, Leishear K et al. Tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005: 65: 9328-9337.
51. Rasheed S, Mao Z, Chan J M, Chan L S. Is melanoma a stem cell tumor? Identification of neurogenic proteins in trans-differentiated cells. J Transl Med 2005: 3: 14.
52. Lammerding-Koppel M, Noda S, Blum A, Schaumburg-Lever G, Rassner G, Drews U. Immunohistochemical localization of muscarinic acetylcholine receptors in primary and metastatic malignant melanomas. J Cutan Pathol 1997: 24: 137-144.
53. Grichnik J M, Burch J A, Schulteis R D et al. Melanoma, a tumor based on a mutant stem cell ? J Invest Dermatol 2006: 126: 142-153.
54. Scharenberg C W, Harkey M A, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002: 99: 507-512.
55. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005: 5: 275-284.
56. Frank N Y, Margaryan A, Huang Y et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 2005: 65: 4320-4333.
57. Wang E, Voiculescu S, LePoole I C et al. Clonal persistence and evolution during a decade of recurrent melanoma. J Invest Dermatol 2006: 126: 1372-1377.
58. Balazs M, Adam Z, Treszl A, Begany A, Hunyadi J, Adany R. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 2001: 46: 222-232.
59. Wiltshire R N, Dennis T R, Sondak V K, Meltzer P S, Trent J M. Application of molecular cytogenetic techniques in a case study of human cutaneous metastatic melanoma. Cancer Genet Cytogenet 2001: 131: 97-103.
60. Willemze R, Jaffe E S, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005: 105: 3768-3785.
61. Zucca E, Cavalli F. Extranodal lymphomas. Ann Oncol 2000: 11: 219-222.
62. Edelson R L. Cutaneous T Cell lymphoma: Mycosis fungoides, sezary syndrome, and other variants. J Am Acad Dermatol 1980: 2: 89-106.
63. Linnemann T, Gellrich S, Lukowsky A et al. Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T-cell lymphoma: Evidence for possible superantigen involvement. Br J Dermatol 2004: 150: 1013-1017.
64. Tan R S, Butterworth C M, McLaughlin H, Malka S, Samman P D. Mycosis fungoides - a disease of antigen persistence. Br J Dermatol 1974: 91: 607-616.
65. Gniadecki R, Lukowsky A, Rossen K, Madsen H O, Thomsen K, Wulf H C. Bone marrow precursor of extranodal T-cell lymphoma. Blood 2003: 102: 3797-3799.
66. Gniadecki R. Neoplastic stem cells in cutaneous lymphomas: Evidence and clinical implications. Arch Dermatol 2004: 140: 1156-1160.
67. Diamandidou E, Cohen P R, Kurzrock R. Mycosis fungoides and sezary syndrome. Blood 1996: 88: 2385-2409.
68. Hoppe R T, Wood G S, Abel E A. Mycosis fungoides and the sezary syndrome: Pathology, staging, and treatment. Curr Probl Cancer 1990: 14: 293-371.
69. Berg K D, Brinster N K, Huhn K M et al. Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med 2001: 345: 1458-1463.
70. Wulf G G, Wang R Y, Kuehnle I et al. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 2001: 98: 1166-1173.
71. Costello R T, Mallet F, Gaugler B et al. Human acute myeloid leukemia CD34+/. Cancer Res 2000: 60: 4403-4411.
72. Holyoake T, Jiang X, Eaves C, Eaves A. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 1999: 94: 2056-2064.
73. Guan Y, Gerhard B, Hogge D E. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 2003: 101: 3142-3149.